No federal psychedelic bill gets committee markup or floor action this session; movement confined to California therapeutic access.

Multiple perspectives — including lawmakers, veterans' advocates, and drug enforcement officials — all agree that federal psychedelic legislation won't get a formal committee vote or floor debate this congressional session. The only meaningful legal progress is happening at the state level in California.

Consensus of 4 agents: legislator, veterans_advocate, dea_officer. 0 dissenting.